祖细胞来源再生标志物对丙型肝炎病毒相关肝硬化结局的影响(ANRS CO12 CirVir队列)
在337例代偿期丙型肝炎病毒相关肝硬化患者中,肝活检K7阳性肝细胞者198例(58.8%),其中广泛染色40例(11.9%);EpCAM阳性肝细胞者203例(60.6%)。中位随访54.2个月,47例(14%)发生失代偿事件,37例(11%)诊断肝细胞癌。广泛K7染色与失代偿事件独立相关(HR 3.00,95%CI 1.30-6.89,P=0.010),EpCAM表达与肝细胞癌发生独立相关(HR 2.37,95%CI 1.07-5.23,P=0.033)。
要点
- 代偿期HCV相关肝硬化患者中,肝活检K7广泛染色与失代偿事件独立相关(HR 3.00)。
- EpCAM表达与肝细胞癌发生独立相关(HR 2.37),年龄和低凝血酶原比率亦相关。
- 祖细胞来源再生标志物K7和EpCAM免疫染色可标记更易发生并发症的肝硬化阶段。
核心结论
- 肝活检中K7和EpCAM免疫染色所描绘的祖细胞来源再生,标记了代偿期HCV相关肝硬化中更易发生并发症的阶段。
研究设计与样本
- 前瞻性ANRS CO12 CirVir队列中,选取纳入研究前2年内有肝活检的Child-Pugh A级无并发症HCV相关肝硬化患者,共337例符合条件(男性67%,中位年龄52岁)。
- 采用K7和EpCAM免疫染色识别中间肝胆细胞,用多变量Cox比例风险回归模型研究胆汁标志物表达对失代偿事件和肝细胞癌发生的影响。
主要发现
- 198例(58.8%)肝活检有K7阳性肝细胞,其中40例(11.9%)为广泛染色;203例(60.6%)有EpCAM阳性肝细胞。
- 中位随访54.2个月期间,47例(14%)发生失代偿事件,37例(11%)诊断肝细胞癌。
- 广泛K7染色与失代偿事件发生独立相关(HR 3.00,95%CI 1.30-6.89,P=0.010)。
- EpCAM表达与肝细胞癌发生独立相关(HR 2.37,95%CI 1.07-5.23,P=0.033),年龄和低凝血酶原比率亦与肝细胞癌发生独立相关。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
UNLABELLED: Progenitor-derived regeneration gives rise to the aberrant expression of biliary markers such as cytokeratin 7 (K7) and epithelial cell adhesion molecule (EpCAM) in hepatocytes. We aimed to describe the expression of these molecules in patients with compensated hepatitis C virus (HCV)-related cirrhosis and to investigate its potential influence on cirrhosis complications. Among patients with Child-Pugh A uncomplicated HCV-related cirrhosis enrolled in the prospective ANRS CO12 CirVir cohort, we selected individuals with a liver biopsy collected within 2 years before inclusion in the study. K7 and EpCAM immunostaining identified intermediate hepatobiliary cells. The influence of biliary marker expres-sion in hepatocytes on decompensation events and the occurrence of hepatocellular carcinoma (HCC) was studied using a multivariate Cox proportional hazards regression model. Among the 337 patients eligible for the study (men, 67%; median age, 52 years), 198 (58.8%) had biopsies with K7-positive hepatocytes including extensive staining in 40 (11.9%) and 203 had EpCAM-positive hepatocytes (60.6%). During follow-up (median, 54.2 months), 47 patients (14%) experienced a decompensation event, and HCC was diagnosed in 37 patients (11%). Extensive K7 staining was independently associated with the occurrence of a decompensation event (hazard ratio [HR], 3.00; 95% confidence interval [CI], 1.30-6.89; P = 0.010). EpCAM expression was independently associated with HCC occurrence (HR, 2.37; 95% CI, 1.07-5.23; P =0.033) along with age and a low prothrombin ratio. CONCLUSION: Progenitor-derived regeneration depicted by K7 and EpCAM immunostaining of hepatocytes in liver biopsies of patients with compensated HCV-related cirrhosis marks a cirrhosis stage more prone to develop complications. (HEPATOLOGY 2018; 68:1534-1548).
引用
- Wendum D, Layese R, Ganne-Carrié N, et al. Influence of Progenitor-Derived Regeneration Markers on Hepatitis C Virus-Related Cirrhosis Outcome (ANRS CO12 CirVir Cohort). Hepatology. 2018. PMID: 29637581. doi:10.1002/hep.29927
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。